Unveiling DNA methylation: early diagnosis, risk assessment, and therapy for endometrial cancer
Authors:
Top Cited Papers
Open Access
- 20 January 2025
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 14, 1455255
Abstract
Endometrial cancer (EC), one of the most common gynecologic malignancies worldwide, poses a significant burden particularly among young women, with poor treatment outcomes and prognosis for advanced and recurrent patients. Epigenetic changes, encompassing DNA methylation, are involved in the occurrence and progression of tumors and hold promise as effective tools for screening, early diagnosis, treatment strategy, efficacy evaluation, and prognosis analysis. This review provides a comprehensive summary of DNA methylation-based early diagnostic biomarkers in EC, with a focus on recent valuable research findings published in the past two years. The discussion is organized according to sample sources, including cervical scraping, vaginal fluid, urine, blood, and tissue. Additionally, we outline the role of DNA methylation in EC risk assessment, such as carcinogenesis risk, feasibility of fertility preservation approaches, and overall prognosis, aiming to provide personalized treatment decisions for patients. Finally, we review researches on DNA methylation in resistance to first-line treatment of EC and the development of new drugs, and envision the future applications of DNA methylation in EC.Keywords
This publication has 133 references indexed in Scilit:
- H3K27me3 deficiency in dedifferentiated carcinoma and carcinosarcoma of the endometriumVirchows Archiv, 2023
- Potential of blood-based biomarker approaches in endometrium and breast cancer: a case-control comparison studyArchives of Gynecology and Obstetrics, 2022
- Establishment and validation of a prognostic nomogram based on a novel five‐DNA methylation signature for survival in endometrial cancer patientsCancer Medicine, 2020
- Physical activity, obesity and sedentary behavior in cancer etiology: epidemiologic evidence and biologic mechanismsMolecular Oncology, 2020
- Association of Endometrial Cancer Risk With Postmenopausal Bleeding in WomenJAMA Internal Medicine, 2018
- DNA methylation profiles in cancer diagnosis and therapeuticsClinical and Experimental Medicine, 2017
- Discovery and validation of methylation markers for endometrial cancerInternational Journal of Cancer, 2014
- Correlation between the DNA global methylation status and progesterone receptor expression in normal endometrium, endometrioid adenocarcinoma and precursorsVirchows Archiv, 2004
- Hypermethylation in promoter region of E‐cadherin gene is associated with tumor dedifferention and myometrial invasion in endometrial carcinomaCancer, 2003
- PTEN methylation is associated with advanced stage and microsatellite instability in endometrial carcinomaInternational Journal of Cancer, 2000